HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico

被引：0
|
作者：
Yvonne N. Flores
David M. Bishai
Attila Lőrincz
Keerti V. Shah
Eduardo Lazcano-Ponce
Mauricio Hernández
Víctor Granados-García
Ruth Pérez
Jorge Salmerón
机构：
[1] Instituto Mexicano del Seguro Social,Unidad de Investigación Epidemiológica y en Servicios de Salud
[2] Johns Hopkins University,Department of Population, Family, and Reproductive Health
[3] Bloomberg School of Public Health,Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine
[4] Queen Mary University of London,Department of Molecular Microbiology and Immunology
[5] Johns Hopkins University,Centro de Investigación en Salud Poblacional
[6] Bloomberg School of Public Health,Secretaria de Prevención y Promoción de la Salud
[7] Instituto Nacional de Salud Pública,Unidad de Investigación en Economía de la Salud
[8] Secretaría de Salud,Departamento de Abastecimiento, Instituto Mexicano del Seguro Social
[9] Instituto Mexicano del Seguro Social,undefined
[10] Hospital General Regional No. 1,undefined
来源：
Cancer Causes & Control | 2011年 / 22卷
关键词：
Cost-effectiveness; Cervical cancer; HPV; Screening; Mexico;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：261 / 272
页数：11
相关论文
共 50 条
  • [21] Is cytology/HPV co-testing for cervical cancer screening useful in Japan?
    Oishi, Tetsuro
    Kigawa, Junzo
    Iwanari, Osamu
    Kasai, Tokuzo
    Kurokawa, Tetsuji
    Hamada, Masao
    Fujita, Hiromasa
    Fujiwara, Hiroyuki
    Yokoyama, Masatoshi
    Sakuragi, Noriaki
    Harada, Tasuku
    Suzuki, Mitsuaki
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2022, 158 (01) : 187 - 193
  • [22] Efficacy of HPV DNA Testing With Cytology Triage and/or Repeat HPV DNA Testing in Primary Cervical Cancer Screening
    Naucler, Pontus
    Ryd, Walter
    Tornberg, Sven
    Strand, Anders
    Wadell, Goran
    Elfgren, Kristina
    Radberg, Thomas
    Strander, Bjorn
    Forslund, Ola
    Hansson, Bengt-Goran
    Hagmar, Bjorn
    Johansson, Bo
    Rylander, Eva
    Dillner, Joakim
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (02): : 88 - 99
  • [23] SCREENING FOR CANCER - IS IT COST-EFFECTIVE
    SCHWARTZ, MK
    CLINICAL CHEMISTRY, 1993, 39 (11B) : 2397 - 2403
  • [24] HPV vaccination in China needs to be more cost-effective
    Yin, Yue
    LANCET, 2017, 390 (10104): : 1735 - 1736
  • [25] Screening for colorectal cancer: Colonoscopy is more cost-effective than fecal occult blood test.
    Delco, F
    Sonnenberg, A
    Inadomi, JM
    GASTROENTEROLOGY, 1999, 116 (04) : A394 - A394
  • [26] IS ANCILLARY TESTING PERFORMED ON CYTOLOGY SPECIMENS COST-EFFECTIVE?
    Krishnamurthy, S.
    ACTA CYTOLOGICA, 2010, 54 (03) : 386 - 386
  • [27] HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status
    Richardson, Lyndsay Ann
    El-Zein, Mariam
    Ramanakumar, Agnihotram V.
    Ratnam, Samuel
    Sangwa-Lugoma, Ghislain
    Longatto-Filho, Adhemar
    Cardoso, Marly Augusto
    Coutlee, Francois
    Franco, Eduardo L.
    CANCER CYTOPATHOLOGY, 2015, 123 (12) : 745 - 754
  • [28] Lung Cancer Surgery: VATS is more cost-effective than Thoracotomy
    Lorenz, Judith
    ZENTRALBLATT FUR CHIRURGIE, 2020, 145 (01): : 11 - +
  • [29] Results of delayed triage by HPV testing and cytology in the Norwegian Cervical Cancer Screening Programme
    Haldorsen, Tor
    Skare, Gry Baadstrand
    Ursin, Giske
    Bjorge, Tone
    ACTA ONCOLOGICA, 2015, 54 (02) : 200 - 209
  • [30] Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none
    El-Zein, Mariam
    Richardson, Lyndsay
    Franco, Eduardo L.
    JOURNAL OF CLINICAL VIROLOGY, 2016, 76 : S62 - S68
12345